Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice-Reference-Cited by-同舟云学术

Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice

Published:2018-05-11 Issue:2 Volume:68 Page:634-651
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Raevens Sarah¹,Geerts Anja¹,Paridaens Annelies¹,Lefere Sander¹^ORCID,Verhelst Xavier¹,Hoorens Anne²,Van Dorpe Jo²,Maes Tania³,Bracke Ken R.³,Casteleyn Christophe⁴⁵,Jonckx Bart⁶,Horvatits Thomas⁷⁸,Fuhrmann Valentin⁷⁸,Van Vlierberghe Hans¹,Van Steenkiste Christophe¹,Devisscher Lindsey¹,Colle Isabelle¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Hepatology Research Unit, Ghent University, Ghent University Hospital; Ghent Belgium

2. Department of Pathology; Ghent University and Ghent University Hospital; Ghent Belgium

3. Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine; Ghent University Hospital; Ghent Belgium

4. Department of Morphology, Faculty of Veterinary Medicine; Ghent University; Merelbeke Belgium

5. Applied Veterinary Morphology, Faculty of Pharmaceutical; Biomedical and Veterinary Sciences, University of Antwerp; Wilrijk Belgium

6. ThromboGenics NV; Heverlee Belgium

7. Division of Gastroenterology & Hepatology, Department of Internal Medicine III; Medical University of Vienna; Vienna Austria

8. Department of Intensive Care Medicine; University Medical Center Hamburg-Eppendorf; Hamburg Germany

Funder

Fonds Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29579/fullpdf

Reference42 articles.

1. Hepatopulmonary syndrome-a liver-induced lung vascular disorder;Rodriguez-Roisin;N Engl J Med,2008

2. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates;Fallon;Gastroenterology,2008

3. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation;Arguedas;Hepatology,2003

4. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome;Fallon;Gastroenterology,1997

5. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction;Luo;J Hepatol,1998

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Placental growth factor mediates pathological uterine angiogenesis by activating the NFAT5-SGK1 signaling axis in the endometrium: implications for preeclampsia development;Biological Research;2024-08-17

2. Elevated circulating BMP9 aggravates pulmonary angiogenesis in hepatopulmonary syndrome rats through ALK1‐Endoglin‐Smad1/5/9 signalling;European Journal of Clinical Investigation;2024-04-09

3. Pathophysiological basis of hepatopulmonary syndrome;GASTROENTEROLOGY;2024-04-07

4. Cholangiocyte-derived exosomal long noncoding RNA PICALM-AU1 promotes pulmonary endothelial cell endothelial-mesenchymal transition in hepatopulmonary syndrome;Heliyon;2024-02

5. Hepatopulmonary syndrome: diagnosis and treatment;EMERGENCY MEDICINE;2024-01-11